A Less-Hazy Crystal Ball: Updates on FDA Inspections During the COVID-19 Era
Back in May, the FDA issued its “Resiliency Roadmap for FDA Inspectional Oversight” report describing the FDA’s oversight activities after the onset … more
Back in May, the FDA issued its “Resiliency Roadmap for FDA Inspectional Oversight” report describing the FDA’s oversight activities after the onset … more
Like all entities faced with navigating the challenges of resuming operations as the COVID-19 pandemic progresses, FDA too has had to adapt … more